91![Possible mechanisms of the disease Possible mechanisms of the disease](https://www.pdfsearch.io/img/5c510c189524aee7643fa5694293f744.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
92![Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or](https://www.pdfsearch.io/img/552d60ec7599393b8d6eed20a1ff4d99.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
93![Living well with lupus Lupus Canada FACT SHEET Living well with lupus Lupus Canada FACT SHEET](https://www.pdfsearch.io/img/8ccfa474ec7de5623d8f2541c688c763.jpg) | Add to Reading ListSource URL: www.lupuscanada.orgLanguage: English - Date: 2014-11-11 15:39:35
|
---|
94![TREANDA® (bendamustine hydrochloride) for Injection TREANDA® (bendamustine hydrochloride) for Injection](https://www.pdfsearch.io/img/e9663d2168f6b5ccf17626c623bee07e.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:11:20
|
---|
95![NIH Public Access Author Manuscript Mult Scler Relat Disord. Author manuscript; available in PMC 2014 February 17. NIH-PA Author Manuscript NIH Public Access Author Manuscript Mult Scler Relat Disord. Author manuscript; available in PMC 2014 February 17. NIH-PA Author Manuscript](https://www.pdfsearch.io/img/b05e03736e08da5884feb6bf12aba1eb.jpg) | Add to Reading ListSource URL: myelitis.orgLanguage: English - Date: 2014-04-11 03:31:05
|
---|
96![Microsoft Word - Rituximab Trial Participation - for News page_v2 Microsoft Word - Rituximab Trial Participation - for News page_v2](https://www.pdfsearch.io/img/79d16b7f745b770bc0f9397b9db2ffba.jpg) | Add to Reading ListSource URL: fm-cfs.caLanguage: English - Date: 2013-12-09 15:36:06
|
---|
97![Microsoft Word - Rituxan DHCP Letter_FINAL.doc Microsoft Word - Rituxan DHCP Letter_FINAL.doc](https://www.pdfsearch.io/img/76ce9de636aeab365fbc81e5fc4f6392.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
98![Lupus Canada Bulletin Registered Charity Number[removed]RR0001 (ISSN[removed]) Lupus Canada Bulletin Registered Charity Number[removed]RR0001 (ISSN[removed])](https://www.pdfsearch.io/img/ec49974cb1acb632e182f8968163fb56.jpg) | Add to Reading ListSource URL: www.lupuscanada.orgLanguage: English - Date: 2014-11-11 11:15:42
|
---|
99![Page 1 labeling\proposedlabeltext.doc DEC Page 1 labeling\proposedlabeltext.doc DEC](https://www.pdfsearch.io/img/5364e1a8c000c933da5eab6247070061.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 15:46:04
|
---|
100![CimzIa(ß (certolizumab pegol) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIAQ! safely and effectively. See full prescribing information for CIMZIA. CimzIa(ß (certolizumab pegol) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIAQ! safely and effectively. See full prescribing information for CIMZIA.](https://www.pdfsearch.io/img/4f8d79b68cba830acb55524909d74bf0.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-12-12 16:11:01
|
---|